Ixprim

Tramadol Hydrochloride, Paracetamol, the active ingredient in Ixprim, is an opioid analgesic and non‑opioid analgesic presented as a tablet for oral use. It treats moderate to severe acute pain, post‑operative pain and musculoskeletal pain in adult patients. It is indicated for short‑term management of pain where opioid therapy is appropriate, providing both central analgesia and antipyretic effects.

GNH USA supplies Ixprim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Ixprim combines an opioid and a non‑opioid analgesic, targeting central opioid receptors and peripheral prostaglandin pathways, to manage pain across several clinical settings. - Moderate to severe acute pain: provides rapid, effective analgesia for sudden, intense pain episodes. - Post‑operative pain: helps control pain following surgical procedures, facilitating recovery. - Musculoskeletal pain: alleviates pain associated with muscle, joint, or bone conditions, improving function. - Dental pain: offers effective relief after dental extractions or procedures. - Trauma pain: provides analgesia for pain resulting from injuries such as fractures or sprains.

Ixprim may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: feeling of queasiness or urge to vomit. - Dizziness: light‑headed sensation or loss of balance. - Constipation: reduced bowel movements or hard stools. - Headache: mild to moderate head pain. - Somnolence: increased sleepiness or fatigue. - Dry mouth: reduced salivation causing throat dryness.

Serious or Rare Side Effects: - Seizures: convulsive episodes, especially at high doses or with interacting drugs. - Respiratory depression: slowed or shallow breathing that may be life‑threatening. - Serotonin syndrome: agitation, hyperthermia, tremor when combined with serotonergic agents. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: sudden severe allergic reaction with airway compromise. - Hepatic injury: elevated liver enzymes or jaundice.

When prescribing Ixprim, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: adjust use in patients with impaired kidney clearance. - Monitor hepatic status: use caution in liver disease and avoid excessive dosing. - Evaluate for seizure history: tramadol may lower seizure threshold. - Avoid concurrent MAO inhibitors: risk of serotonin syndrome. - Use with caution in patients with respiratory disorders: potential for respiratory depression. - Store at ambient temperature: keep tablets in original packaging, protect from moisture and heat.

Ixprim can interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause serotonin syndrome. - Selective serotonin reuptake inhibitors (SSRIs) and SNRIs: increase risk of serotonin syndrome. - CNS depressants (benzodiazepines, alcohol): enhance sedation and respiratory depression. - CYP2D6 inhibitors (e.g., quinidine, fluoxetine): raise tramadol plasma levels, risk of toxicity. - Other opioids: additive opioid effects leading to respiratory compromise.

Moderate Interactions (Monitor Closely): - Antihypertensives: tramadol may affect blood pressure control. - Antidiabetic agents: possible alteration of glucose levels. - Warfarin: paracetamol may increase INR, requiring monitoring. - Antihistamines: may increase sedation. - Anticonvulsants: may affect seizure threshold.